Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity (vol 15, pg 201, 2011)

被引：4
|
作者：
Sorensen, Benny [1 ]
Spahn, Donat R. [2 ]
Innerhofer, Petra [3 ]
Spannagl, Michael [4 ]
Rossaint, Rolf [5 ]
机构：
[1] Guys & St Thomas Hosp & NHS Trust Fdn, Univ London Kings Coll, Haemostasis Res Unit, Dept Haematol & Oncol,Ctr Haemostasis & Thrombosi, London SE1 7EH, England
[2] Univ Zurich Hosp, Inst Anesthesiol, CH-8091 Zurich, Switzerland
[3] Innsbruck Med Univ, Dept Anaesthesiol & Crit Care Med, A-6020 Innsbruck, Austria
[4] Univ Hosp Munich, Dept Anaesthesiol, Working Grp Perioperat Hemostasis, D-80336 Munich, Germany
[5] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Anaesthesiol, D-52074 Aachen, Germany
来源：
CRITICAL CARE | 2011年 / 15卷 / 02期
关键词：
D O I：
10.1186/cc10094
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
    Benny Sørensen
    Donat R Spahn
    Petra Innerhofer
    Michael Spannagl
    Rolf Rossaint
    Critical Care, 15
  • [2] Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
    Sorensen, Benny
    Spahn, Donat R.
    Innerhofer, Petra
    Spannagl, Michael
    Rossaint, Rolf
    CRITICAL CARE, 2011, 15 (01):
  • [3] Erratum to: Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
    Benny Sørensen
    Donat R Spahn
    Petra Innerhofer
    Michael Spannagl
    Rolf Rossaint
    Critical Care, 15
  • [4] Prothrombin complex concentrates-evaluation of safety and thrombogenicity
    Sorensen, B.
    Sapahn, D.
    Spannagl, M.
    Rossaint, R.
    CIRUGIA Y CIRUJANOS, 2013, 81 (03):
  • [5] Clinical effectiveness and safety outcomes associated with prothrombin complex concentrates
    Ashley Hedges
    James C. Coons
    Melissa Saul
    Roy E. Smith
    Journal of Thrombosis and Thrombolysis, 2016, 42 : 6 - 10
  • [6] Clinical effectiveness and safety outcomes associated with prothrombin complex concentrates
    Hedges, Ashley
    Coons, James C.
    Saul, Melissa
    Smith, Roy E.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2016, 42 (01) : 6 - 10
  • [7] A NOVEL RAT MODEL OF THROMBOGENICITY - ITS USE IN EVALUATION OF PROTHROMBIN COMPLEX CONCENTRATES AND HIGH-PURITY FACTOR-IX CONCENTRATES
    MCLAUGHLIN, LF
    DRUMMOND, O
    MACGREGOR, IR
    THROMBOSIS AND HAEMOSTASIS, 1992, 68 (05) : 511 - 515
  • [8] Comparative in vitro investigation of prothrombin complex concentrates (vol 24, pg 175, 1998)
    Römisch, J
    Bonik, K
    Müller, HG
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1998, 24 (03): : 299 - 301
  • [9] Non-clinical safety and efficacy of prothrombin complex concentrates (PCC) for the reversal of dabigatran mediated anticoagulation
    Herzog, E.
    Kaspereit, F.
    Krege, W.
    Van Joanne, R.
    Dickneite, G.
    Pragst, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 693 - 693
  • [10] Book Review of Clinical Manual of Adolescent Substance Abuse Treatment (vol 201, pg 1004, 2013)
    Pumariega, Andres J.
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2014, 202 (01) : 78 - 78
12345